Skip to main content
Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
4.920
+0.130 (2.71%)
At close: Nov 20, 2024, 4:00 PM
4.910
-0.010 (-0.20%)
Pre-market: Nov 21, 2024, 4:03 AM EST

Ardelyx Revenue

Ardelyx had revenue of $98.24M in the quarter ending September 30, 2024, with 74.21% growth. This brings the company's revenue in the last twelve months to $251.85M, up 87.57% year-over-year. In the year 2023, Ardelyx had annual revenue of $124.46M with 138.61% growth.

Revenue (ttm)
$251.85M
Revenue Growth
+87.57%
P/S Ratio
4.57
Revenue / Employee
$943,255
Employees
267
Market Cap
1.17B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023124.46M72.30M138.61%
Dec 31, 202252.16M42.06M416.57%
Dec 31, 202110.10M2.53M33.36%
Dec 31, 20207.57M2.29M43.36%
Dec 31, 20195.28M2.67M102.57%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Aveanna Healthcare Holdings 1.98B
OPKO Health 711.41M
The Pennant Group 652.30M
ANI Pharmaceuticals 555.46M
Phreesia 389.96M
Artivion 384.90M
Maravai LifeSciences Holdings 276.92M
Gyre Therapeutics 105.03M
Revenue Rankings

ARDX News

More News